Related Experiment Video

Updated: Nov 3, 2025

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.6K

Retraction: Impact and Cost-effectiveness of Human Papillomavirus Vaccination Campaigns

Allison Portnoy, Nicole G Campos, Stephen Sy

    Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
    |June 2, 2021
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice08:52

    Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

    Published on: February 22, 2019

    10.9K
    A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions13:56

    A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

    Published on: July 18, 2013

    11.4K

    Related Concept Videos

    Vaccinations01:51

    Vaccinations

    Overview
    48.1K
    Cancer Vaccines01:30

    Cancer Vaccines

    Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
    Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
    595